The U.S. Food and Drug Administration (FDA) has approved for review a Biologics License Application (BLA) for AVT06, Alvotech ...

TekniPlex, an advanced materials science company, has named long-tenured senior executive Suj Mehta as CEO of its Healthcare ...

Flourish Research, a multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and ...

Asahi Kasei Bioprocess America Inc. (AKBA), a leader in advanced filtration and fluid management solutions for the ...

Seqens, a developer and producer of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, has named Pascal Villemagne as Chief Executive Officer, effective April ...

Arcus Biosciences, Inc. has regained ownership of casdatifan, a potential treatment for clear cell renal cell carcinoma (ccRCC), after Gilead’s time-limited exclusive option rights to casdatifan ...

The US Food and Drug Administration (FDA) has accepted for priority review Sanofi’s supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Innovative approaches to streamlining biologics production with integrated continuous technologies. Continuous manufacturing ...

Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.